The Role of Metabolic Activation in Drug Toxicity

References

• Miller E. C., Miller J. A. The presence and significance of bound aminoazo dyes in the livers of rats fed p-dimethylaminoazobenzene. Cancer Res. 1947; 7: 468–480
   Web of Science ®Google Scholar
• Miller J. A., Miller E. C. The carcinogenic aminoazo dyes. Adv. Cancer Res. 1953; 1: 339–396
   PubMed Web of Science ®Google Scholar
• Miller E. C., Miller J. A. Mechanisms of chemical carcinogenesis: Nature of proximate carcinogens and interactions with macromolecules. Pharmacol. Rev. 1966; 18: 805–838
   PubMed Web of Science ®Google Scholar
• Miller E. C. Some current perspectives on chemical carcinogenesis in humans and experimental animals: Presidential address. Cancer Res. 1978; 38: 1479–1496
   PubMed Web of Science ®Google Scholar
• Miller E. C., Miller J. A. Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer 1981; 47: 2327–2345
   PubMed Web of Science ®Google Scholar
• Beland F. A., Kadlubar F. F. Formation and persistence of ary-lamine DNA adducts in vivo. Environ. Health Perspectives 1985; 62: 19–30
   PubMed Web of Science ®Google Scholar
• Brodie B. B., Cho A. K., Krishna G. W.D. Reid Drug metabolism in man: Past, present, and future. Ann. NY Acad. Sci. 1971; 179: 11–18
   PubMed Web of Science ®Google Scholar
• Gillette J. R., Mitchell J. R., Brodie B. B. Biochemical mechanisms of drug toxicity. Ann. Rev. Pharmacol. 1974; 14: 271–288
   Google Scholar
• Brodie B. B., Reid W. D., Cho A. K., Sipes G., Krishna G., Gillette J. R. Possible mechanism of liver necrosis caused by aromatic organic compounds. Proc. Natl. Acad. Sci. USA 1971; 68: 160–164
   PubMed Web of Science ®Google Scholar
• Jollow D. J., Mitchell J. R., Zampaglione N., Gillette J. R. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 1974; 11: 151–169
   PubMed Web of Science ®Google Scholar
• Zampaglione N., Jollow D. J., Mitchell J. R., Stripp B., Hamrick M., Gillette J. R. Role of detoxifying enzymes in bromobenzene-induced liver necrosis. J. Pharmacol. Exp. Ther. 1973; 187: 218–227
   PubMed Web of Science ®Google Scholar
• Boyd E. M., Bereczky G. M. Liver necrosis from paracetamol. Br. J. Pharmacol. 1966; 26: 606–614
   PubMed Web of Science ®Google Scholar
• Davidson D. G. D., Eastham W. N. Acute liver necrosis following overdose of paracetamol. Br. Med. J. 1966; 5512: 497–499
   Web of Science ®Google Scholar
• Thompson J. S., Prescott L. F. Liver damage and impaired glucose tolerance after paracetamol overdosage. Br. Med. J. 1966; 5512: 506–507
   Google Scholar
• Mitchell J. R., Jollow D. J., Potter W. Z., Davis D. C., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J. Pharmacol. Exp. Ther. 1973; 187: 185–194
   PubMed Web of Science ®Google Scholar
• Jollow D. J., Mitchell J. R., Potter W. Z., Davis D. C., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J. Pharmacol. Exp. Ther. 1973; 187: 195–202
   PubMed Web of Science ®Google Scholar
• Potter W. Z., Davis D. C., Mitchell J. R., Jollow D. J., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis. III. Cytochrome P-450-mediated covalent binding in vitro. J. Pharmacol. Exp. Ther. 1973; 187: 203–210
   PubMed Web of Science ®Google Scholar
• Mitchell J. R., Jollow D. J., Potter W. Z., Gillette J. R., Brodie B. B. Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J. Pharmacol. Exp. Ther. 1973; 187: 211–217
   PubMed Web of Science ®Google Scholar
• Jollow D. J., Thorgeirsson S. S., Potter W. Z., Hashimoto M., Mitchell J. R. Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. Pharmacology 1974; 12: 251–271
   PubMed Web of Science ®Google Scholar
• Hinson J. A., Pohl L. R.T, Monks J., Gillette J. R. Acetaminophen-induced hepatotoxicity. Life Sci. 1981; 29: 107–116
   PubMed Web of Science ®Google Scholar
• Dahlin D. C., Miwa G. T., Lu A. Y. H., Nelson S. D. N-Acetyl-p-benzoquinone imine: A cytochrome P-450-mediated oxidation product of acetaminophen. Proc. Natl. Acad. Sci. USA 1984; 81: 1327–1331
   PubMed Web of Science ®Google Scholar
• Coon M. J., Koop D. R., Reeve L. E., Crump B. L. Alcohol metabolism and toxicity: Role of cytochrome P-450. Fundam. Appl. Toxicol. 1984; 4: 134–143
   PubMedGoogle Scholar
• Harvison P. J., Guengerich F. P., Rashed M. S., Nelson S. D. Cytochrome P-450 isozyme selectivity in the oxidation of acetaminophen. Chem. Res. Toxicol. 1988; 1: 49–52
   Google Scholar
• Raucy J. L., Lasker J. M., Lieber C. S., Black M. Acetaminophen activation by human liver cytochromes P450IIE1 and P450IA2. Arch. Biochem. Biophys. 1989; 271: 270–283
   PubMed Web of Science ®Google Scholar
• Lee C. A., Thummel K. E., Kalhorn T. F., Nelson S. D., Slattery J. T. Inhibition and activation of acetaminophen reactive metabolite formation by caffeine. Drug Metab. Dispos. 1991; 19: 348–353
   PubMed Web of Science ®Google Scholar
• Hinson J. A., Monks T. J., Hong M., Highet R. J., Pohl L. R. 3-(Glutathion-5-yl)acetaminophen: A biliary metabolite of acetaminophen. Drug Metab. Dispos. 1982; 10: 47–50
   PubMed Web of Science ®Google Scholar
• Coles B., Wilson I., Wardman P., Hinson J. A., Nelson S. D., Ketterer B. The spontaneous and enzymatic reaction of N-acetyl-/?-benzoquinonimine with glutathione: A stopped-flow kinetic study. Arch. Biochem. Biophys 1988; 264: 253–260
   PubMed Web of Science ®Google Scholar
• Prescott L. F. Paracetamol overdosage. Pharmacological considerations and clinical management. Drugs 1983; 25: 290–314
   PubMed Web of Science ®Google Scholar
• Nelson S. D., Pearson P. G. Covalent and noncovaient interactions in acute lethal cell injury caused by chemicals. Annu. Rev. Phar-amocol. Toxicol. 1990; 30: 169–195
   PubMed Web of Science ®Google Scholar
• Pohl L. R., Satoh H., Christ D. D. The immunologic and metabolic basis of drug hypersensitivities. Annu. Rev. Pharmacol. Toxicol. 1988; 28: 367–387
   PubMed Web of Science ®Google Scholar
• Hinson J. A., Roberts D. W. Role of covalent and noncovaient interactions in cell toxicity: Effects on proteins. Annu. Rev. Pharmacol. Toxicol. 1992; 32: 271–510
   PubMedGoogle Scholar
• O'Brien P. J. Molecular mechanisms of quinone cytotoxicity. Chem.-Biol. Interact. 1991; 80: 1–41
   PubMed Web of Science ®Google Scholar
• Pumford N. R., Hinson J., Benson R. W., Roberts D. W. Immu-noblot analysis of protein containing 3-(cystein-S-yl)acetaminophen adducts in serum and subcellular liver fractions from acetaminophen-treated mice. Toxicol. Appl. Pharmacol. 1990; 104: 521–532
   PubMed Web of Science ®Google Scholar
• Bartolone J. B., Sparks K., Cohen S. D., Khairallah E. A. Immunochemical detection of acetaminophen-bound liver proteins. Bio-chem. Pharmacol. 1987; 36: 1193–1196
   PubMed Web of Science ®Google Scholar
• Pumford N. R., Martin B. M., Hinson J. A. A metabolite of acetaminophen covalently binds to the 56 kDa selenium binding protein. Biochem. Biophys. Res. Commun. 1992; 182: 1348–1355
   PubMed Web of Science ®Google Scholar
• Bartolone J. B., Birge R. B., Bulera S. J., Bruno M. K., Nis-hanian E. V., Cohen S. D., Khairallah E. A. Purification, antibody production, and partial amino acid sequence of the 58-kDa acetaminophen-binding liver proteins. Toxicol. Appl. Pharmacol. 1992; 113: 19–29
   PubMed Web of Science ®Google Scholar
• Bansal M. P., Mukhopadhyay T., Scott J., Cook R. G., Mukhopad-hyay R., Medina D. DNA sequencing of a mouse liver protein that binds selenium: Implications for selenium's mechanism of action in cancer prevention. Carcinogenesis 1990; 11: 2071–2073
   PubMed Web of Science ®Google Scholar
• Satoh H., Gillette J. R., Davies H. W., Schulick R. D., Pohl L. R. Immunochemical evidence of trifuloroacetylated cytochrome P-450 in the liver of halothane-treated rats. Mol. Pharmacol. 1985; 28: 468–474
   PubMed Web of Science ®Google Scholar
• Kenna J. G., Neuberger J., Williams R. Identification by immu-noblotting of three halothane-induced liver microsomal polypeptide antigens recognized by antibodies in sera from patients with halothane-associated hepatitis. J. Pharmacol. Exp. Ther. 1988; 242: 733–740
   Web of Science ®Google Scholar
• Kenna J. G., Satoh H., Christ D. D., Pohl L. R. Metabolic basis for a drug hypersensitivity: Antibodies in sera from patients with halothane hepatitis recognize liver neoantigens that contain the triflu-oroacetyl group derived from halothane. J. Pharmacol. Exp. Ther. 1988; 245: 1103–1109
   PubMed Web of Science ®Google Scholar
• Pohl L. R., Thomassen D., Pumford N. R., Butler L. E., Satoh H., Ferrans V. J., Perrone A., Martin B. M., Martin J. L. Hapten carrier conjugates associated with halothane hepatitis. Biological Reactive Intermediates IV., C. M. Witmer. Plenum Press, New York 1990; 111–120
   Google Scholar
• Satoh H., Martin B. M., Schulick A. H., Christ D. D., Kenna J. G., Pohl L. R. Human anti-endoplasmic reticulum antibodies in sera of patients with halothane-induced hepatitis are directed against a tri-fluoroacetylated carboxylesterase. Proc. Natl. Acad. Sci. USA 1989; 86: 322–326
   PubMed Web of Science ®Google Scholar
• Martin J. L., Kenna J. G., Martin B. M., Pohl L. R. Trifuloro-acetylated protein disulfide isomerase is a halothane-induced neoanti-gen. Toxicologist 1989; 9: 5
   Google Scholar
• Satoh H., Fukuda Y., Anderson D. K., Ferrans V. J., Gillette J. R., Pohl L. R. Immunological studies on the mechanism of halothane-induced hepatotoxicity: immunohistochemical evidence of trifluoroacetylated hepatocytes. J. Pharmacol. Exp. Ther. 1985; 233: 857–862
   PubMed Web of Science ®Google Scholar
• Rubin R. L., Uetrecht J. P., Jones J. E. Cytotoxicity of oxidative metabolites of procainamide. J. Pharmacol. Exp. Ther. 1987; 242: 833–841
   PubMed Web of Science ®Google Scholar
• Beaune P., Dansette P. M., Mansuy D., Kiffel L., Finck M., Amar C., Leroux J. P., Homburg J. C. Human anti-endoplasmic reticulum autoantibodies appearing in a drug-induced hepatitis are directed against a human liver cytochrome P-450 that hydroxylates the drug. Proc. Natl. Acad. Sci. USA 1987; 84: 551–555
   PubMed Web of Science ®Google Scholar
• Dansette P. M., Amar C., Valadon P., Pons C., Beaune P. H., Mansuy D. Hydroxylation and formation of electrophilic metabolites of tienilic acid and its isomer by human liver microsomes. Catalysis by a cytochrome P-450 IIC different from that responsible for mephenytoin hydroxylation. Biochem. Pharmacol. 1991; 41: 553–560
   PubMed Web of Science ®Google Scholar
• Pumford N. R., Myers T. G., Davila J. C., Highet R. J., Pohl L. R. Immunochemical detection of liver protein adducts of the nonsteroidal antiflammatory drug diclofenac. Chem. Res. Toxicol. 1993; 6: 147–150
   PubMed Web of Science ®Google Scholar
• Baron J., Redlick J. A., Guengerich F. P. An immunohistochemical study of the localizations and distributions of phenobarbital- and 3-methylcholanthrene-inducible cytochromes P-450 isozymes in rat ex-trahepatic tissues. Arch. Biochem. Biophys. 1981; 258: 519–534
   Google Scholar
• Rich K. J., Sesardic D., Foster J. R., Davies D. S., Boobis A. R. Immunohistochemical localization of cytochrome P-450b/e in hepatic and extrahepatic tissues of the rat. Biochem. Pharmacol. 1989; 38: 3305–3322
   PubMed Web of Science ®Google Scholar
• Biichler R., Lindros K. O., Nordling A., Johansson I., Ingelman-Sundberg M. Zonation of cytochrome P450 isozyme expression and induction in rat liver. Eur. J. Biochem. 1992; 204: 407–412
   PubMedGoogle Scholar
• Roberts D. W., Bucci T. J., Benson R. W., Warbritton A. R., McRae T. A., Pumford N. R., Hinson J. A. Immunohistochemical localization and quantification of the 3-(cystein-S-yl)acetaminophen protein adduct in acetaminophen hepatotoxicity. Am. J. Pathol. 1991; 138: 359–371
   PubMed Web of Science ®Google Scholar
• Newton J. F., Yoshimoto M., Bernstein J., Rush G. F., Hook J. B. Acetaminophen nephrotoxicity in the rat. I. Strain differences in nephrotoxicity and metabolism. Toxicol. Appl. Pharmacol. 1983; 69: 291–306
   PubMed Web of Science ®Google Scholar
• Newton J. F., Yoshimoto M. J., Bernstein G. F., Hook J. B. Acetaminophen nephrotoxicity in the rat. II. Strain differences in nephrotoxicity and metabolism and p-aminophenol, a metabolite of acetaminophen. Toxicol. Appl. Pharmacol. 1983; 69: 307–318
   PubMed Web of Science ®Google Scholar
• Newton J. F., Bailie M. B., Hook J. B. Acetaminophen nephrotoxicity in the rat. Renal metabolic activation in vitro. Toxicol. Appl. Pharmacol. 1983; 70: 433–444
   PubMed Web of Science ®Google Scholar
• Carpenter H. M., Mudge G. H. Acetaminophen nephrotoxicity: Studies on renal acetylation and deacetylation. J. Pharmacol. Exp. Ther. 1981; 218: 161–167
   PubMed Web of Science ®Google Scholar
• Pohl L. R., Bhooshan B., Whittaker N. F., Krishna G. Phosgene: A metabolite of chloroform. Biochem. Biophys. Res. Commun. 1977; 79: 684–691
   PubMed Web of Science ®Google Scholar
• Pohl L. R., Krishna G. Deuterium isotope effect in bioactivation and hepatotoxicity of chloroform. Life Sci. 1978; 23: 1067–1072
   PubMed Web of Science ®Google Scholar
• Pohl L. R., Martin J. L., George J. W. Mechanism of metabolic activation of chloroform by rat liver microsomes. Biochem. Pharmacol. 1980; 29: 3271–3276
   PubMed Web of Science ®Google Scholar
• Ilett K. F., Reid W. D., Sipes I. G., Krishna G. Chloroform toxicity in mice: Correlation of renal and hepatic necrosis with covalent binding of metabolites to tissue macromolecules. Exp. Mol. Pathol. 1973; 19: 215–229
   PubMed Web of Science ®Google Scholar
• Pohl L. R., George J. W., Satoh H. Strain and sex differences in chloroform-induced nephrotoxicity. Different rates of metabolism of chloroform to phosgene by the mouse kidney. Drug Metab. Dispos. 1984; 12: 304–308
   PubMed Web of Science ®Google Scholar
• Boyd M. R. Role of metabolic activation in the pathogenesis of chemically induced pulmonary disease: Mechanism of action of the lung-toxic furan, 4-ipomeanol. Environ. Health Persp. 1976; 16: 127–138
   PubMed Web of Science ®Google Scholar
• Ravindranath V., Burka L. T., Boyd M. R. Reactive metabolites from the bioactivation of toxic methylfurans. Science 1984; 224: 884–886
   PubMed Web of Science ®Google Scholar
• Boyd M. R. Evidence for the Clara cell as a site of cytochrome P450-dependent mixed function oxidase activity in lung. Nature 1977; 269: 713–715
   PubMed Web of Science ®Google Scholar
• Smith D., Heath Paraquat D. CRC Crit. Rev. Toxicol. 1976; 4: 411–445
   PubMed Web of Science ®Google Scholar
• Sandy M. S., Moldeus D., Ross D., Smith M. T. Role of redox cycling and lipid peroxidation in bipyridyl herbicide cytotoxicity. Bio-chem. Pharmacol. 1986; 35: 3095–3101
   PubMed Web of Science ®Google Scholar
• DiMonte D., Ross D., Bellomo G., Eklow L., Orrenius S. Alterations in intracellular thiol homeostasis during the metabolism of menadione by isolated rat hepatocytes. Arch. Biochem. Biophys. 1984; 235: 334–342
   PubMed Web of Science ®Google Scholar
• Moore M., Thor H., Moore G., Nelson S., Moldeus F, Orrenius S. The toxicity of acetaminophen and N-acetyl-/?-benzoquinone imine in isolated hepatocytes is associated with thiol depletion and increased cytosolic Ca2+. J. Biol. Chem. 1985; 260: 13035–13040
   PubMed Web of Science ®Google Scholar
• Thor H., Mirabelli F., Salis A., Cohen G. M., Bellomo G., Orrenius S. Alterations in hepatocyte cytoskeleton caused by redox cycling and alkylating quinones. Arch. Biochem. Biophys. 1988; 266: 397–407
   PubMed Web of Science ®Google Scholar
• Rundgren M., Harder S., Nelson S. D., Andersson B. S. Oxidant-induced changes in the cellular energy homeostasis. A study with 3,5-dimethyl N-acetyl-p-benzoquinone imine and isolated hepatocytes. Biochem. Pharmacol. 1990; 40: 239–242
   PubMed Web of Science ®Google Scholar
• Sager P. R., Matheson D. W. Mechanisms of neurotoxicity related to selective disruption of microtubules and intermediate filaments. Toxicology 1988; 49: 479–492
   PubMed Web of Science ®Google Scholar
• Ziegler D. M. role of reversible oxidation-reduction of enzyme thiols-disulfides in metabolic regulation. Ann. Rev. Biochem. 1985; 54: 305–329
   PubMed Web of Science ®Google Scholar
• Scheulen M. E., Kappus H. Metabolic activation of adriamycin by NADPH-cytochrome P-450 reductase, rat liver and heart microsomes and covalent protein binding of metabolites. Biological Reactive Intermediates 11 A, R. Snyder, D. V. Parke, J. J. Kocsis, D. J. Jollow, C. G. Gibson, C. M. Witmer. Plenum Press, New York 1982; 471–485
   Google Scholar
• Ohno Y., Ormstad K., Ross D., Orrenius S. Mechanism of allyl alcohol toxicity and protective effects of low-molecular-weight thiols studied with isolated rat hepatocytes. Toxicol. Appl. Pharmacol. 1985; 78: 169–179
   PubMed Web of Science ®Google Scholar
• Silva J. M., O'Brien P. J. Allyl alcohol and acrolein-induced toxicity in isolated rat hepatocytes. Arch. Biochem. Biophys. 1989; 275: 551–558
   PubMed Web of Science ®Google Scholar
• Tunek A., Piatt K. L., Przybylski M., Oesch F. Multistep metabolic activation of benzene: Effect of superoxide dismutase on cova-lent binding to microsomal macromolecules, and identification of glutathione conjugates using high pressure liquid chromatography and field desorption mass spectrometry. Chem.-Biol. Interact. 1980; 33: 1–17
   PubMed Web of Science ®Google Scholar
• Lunte S. M., Kissinger P. T. Detection and identification of sulf-hydryl conjugates of p-benzoquinone in microsomal incubations of benzene and phenol. Chem.-Biol. Interact. 1983; 47: 195–212
   PubMed Web of Science ®Google Scholar
• Sawahata T., Neal R. A. Biotransformation of phenol to hydroqui-none and catechol by rat liver microsomes. Mol. Pharmacol. 1983; 23: 453–460
   PubMed Web of Science ®Google Scholar
• Smart R. C., Zannoni V. G. DT-Diaphorase and peroxidase influence the covalent binding of the metabolites of phenol, the major metabolite of benzene. Mol. Pharmacol. 1984; 26: 105–111
   PubMed Web of Science ®Google Scholar
• Nerland D. E., Pierce W. M. Identification of N-acetyl-S-(2,5-dihydroxyphenyl)-L-cysteine as a urinary metabolite of benzene, phenol, and hydroquinone. Drug Metab. Dispos. 1990; 18: 958–961
   PubMed Web of Science ®Google Scholar
• Kilkuskie R. E., MacDonald T. L., Hecht S. D. Bleomycin may be activated for DNA cleavage by NADPH-cytochrome P-450 reductase. Biochemistry 1984; 23: 6165–7171
   PubMed Web of Science ®Google Scholar
• Mahmutoglo I., Kappus H. Oxy radical formation during redox cycline of bleomycin-iron (III) complex by NADPH cytochrome P-450 reductase. Biochem. Pharmacol. 1985; 34: 3091–3094
   PubMed Web of Science ®Google Scholar
• Lau S. S., Monks T. J. The contribution of bromobenzene to our current understanding of chemically-induced toxicities. Life Sci. 1988; 42: 1259–1269
   PubMed Web of Science ®Google Scholar
• Witschi H., Malkinson A. M., Thompson J. A. Metabolism and pulmonary toxicity of butylated hydroxytoluene (BHT). Pharmacol. Ther. 1989; 42: 89–113
   PubMed Web of Science ®Google Scholar
• Thompson D. C., Y-Cha N., Trush M. A. The peroxidase-dependent activation of butylated hydroxyanisole and butylated hydroxytoluene (BHT) to reactive intermediates. Formation of BHT-quinone methide via a chemical-chemical interaction. J. Biol. Chem. 1989; 264: 3957–3965
   PubMed Web of Science ®Google Scholar
• Neal R. A., Halpert J. Toxicology of thionsulfur compounds. Annu. Rev. Pharmacol. Toxicol. 1982; 22: 321–329
   PubMed Web of Science ®Google Scholar
• Osawa Y., Highet R. J., Bax A., Pohl L. R. Covalent bonding of the prosthetic heme to protein: A potential mechanism for the suicide inactivation or activation of hemoproteins. Chem. Res. Toxicol. 1989; 2: 131–141
   PubMed Web of Science ®Google Scholar
• DeGroot H., Littauer A., Hugh-Wissemann D., Wissemann P., Noll T. Lipid peroxidation and cell viability in isolated hepatocytes in a redesigned oxystate system: Evaluation of the hypothesis that lipid peroxidation, preferentially induced at low oxygen partial pressures, is decisive for CC14 liver cell injury. Arch. Biochem. Biophys. 1988; 264: 591–599
   PubMed Web of Science ®Google Scholar
• Recknagel R. Carbon tetrachloride hepatotoxicity: Status quo and future prospects. Trends Pharmacol. Sci. 1983; 129–131
   Web of Science ®Google Scholar
• Pohl L. R., Martin J. L., George J. W. Mechanism of metabolic activation of chloroform by rat liver microsomes. Biochem. Pharmacol. 1980; 29: 3271–3276
   PubMed Web of Science ®Google Scholar
• Anders M. W., Lash L. H., Dekant W., Elfarra A. A., Dohn D. R. Biosynthesis and biotransformation of glutathione 5-conjugates to toxic metabolites. CRC Crit. Rev. Toxicol. 1988; 18: 311–341
   Web of Science ®Google Scholar
• Dekant W., Vamvakas S., Anders M. W. Bioactivation of nephrotoxic haloalkenes by glutathione conjugation: Formation of toxic and mutagenic intermediates by cysteine conjugate (3-lyase. Drug Metab. Rev. 1989; 20: 43–83
   PubMed Web of Science ®Google Scholar
• Monks T J., Anders M. W., Dekant W., Stevens J. L., Lau S. S., Van Bladeren P. J. Contemporary issues in toxicology. Glutathione conjugate mediated toxicities. Toxicol. Appl. Pharmacol. 1990; 106: 1–19
   PubMed Web of Science ®Google Scholar
• Dohn D. R., Leininger J. R., Lash L. H., Quebbemann A. J., Anders M. W. Nephrotoxicity of S-(2-chloro-1,1,2-trifluoroethyl) glutathione and S-(2-chloro-1,1,2-trifluoroethyl)-L-cysteine, the glutathione and cysteine conjugates of chlorotrifluoroethene. J. Pharmacol. Exp. Ther. 1985; 235: 851–857
   PubMed Web of Science ®Google Scholar
• Terracini B., Parker V. H. A pathological study on the toxicity of S-dichlorovinyl-L-cysteine. Food Cosmet. Toxicol. 1965; 3: 61–1A
   Google Scholar
• Anderson P. M., Schultze M. O. Cleavage of 5-(1,2-dichlorovinyl)-L-cysteine by an enzyme of bovine origin. Arch. Biochem. Biophys. 1965; Ill: 593–602
   Google Scholar
• Dekant W., Metzler M., Henschler D. Identification of 5–1,2-dichlorovinyl-N-acetyl-cysteine as a urinary metabolite of trichloro-ethylene: A possible explanation for its nephrocarcinogenicity. Biochem. Pharmacol. 1986; 35: 2455–2458
   PubMed Web of Science ®Google Scholar
• Spitznagle L. A., Wirth P. J., Boobis S. W., Thorgeirsson S. S., Nelson W. L. The role of biliary excretion in the hepatotoxicity of furosemide in the mouse. Toxicol. Appl. Pharmacol. 1977; 39: 283–294
   PubMed Web of Science ®Google Scholar
• Graham D. G., Anthony D. C., Boekelheide K., Maschmann N. A., Richards R. G., Wolfram J. W., Shaw B. R. Studies of the molecular pathogenesis of hexane neuropathy. II. Evidence that pyrrole derivatization of lysyl residues leads to protein crosslinking. Toxicol. Appl. Pharmacol. 1982; 64: 415–422
   PubMed Web of Science ®Google Scholar
• Genter M. B., Szakal-Quin G., Anderson C. W., Anthony D. C., Graham D. G. Evidence that pyrrole formation is a pathogenetic step in gamma-diketone neuropathy. Toxicol. Appl. Pharmacol. 1987; 87: 351–362
   PubMed Web of Science ®Google Scholar
• StClair M. B. G., Amarnath V., Moody M. A., Anthony D. C., Anderson D. W., Graham D. G. Pyrrole oxidation and protein cross-linking as necessary steps in the development of gamma-diketone neuropathy. Chem. Res. Toxicol. 1988; I: 179–185
   Google Scholar
• Sioussat T. M., Miller F. J., Boekelheide K. 2,5-Hexanedione-treated tubulin microinjected into sea urchin zygotes induces mitotic abnormalities. Toxicol. Appl. Pharmacol. 1990; 104: 36–46
   PubMed Web of Science ®Google Scholar
• Boekelheide K. 2,5-Hexanedione alters microtubule assembly. II. Enhanced polymerization of crosslinked tubulin. Toxicol. Appl. Pharmacol. 1987; 88: 383–396
   PubMed Web of Science ®Google Scholar
• Nelson S. D., Mitchell J. R., Timbrell J. A., Snodgrass W. R., Corcoran G. B. Isoniazid and iproniazid: Activation of metabolites to toxic intermediates in man and rat. Science 1976; 193: 901–903
   PubMed Web of Science ®Google Scholar
• Nelson S. D., Mitchell J. R., Snodgrass W. R., Timbrell J. A. Hepatotoxicity and metabolism of iproniazid and hydrazine. J., Pharmacol. Exp. Ther. 1978; 206: 574–585
   PubMed Web of Science ®Google Scholar
• Timbrell J. A. The role of metabolism in the hepatotoxicity of isoniazid and iproniazid. Drug Metab. Rev. 1979; 10: 125–147
   PubMed Web of Science ®Google Scholar
• Timbrell J. A., Mitchell J. R., Snodgrass W. R., Nelson S. D. Isoniazid hepatotoxicity: The relationship between covalent binding and metabolism in vivo. J. Pharmacol. Exp. Ther. 1980; 213: 364–369
   PubMed Web of Science ®Google Scholar
• Ravindranath V., Boyd M. R. Metabolic activation of 2-methylfuran by rat microsomal systems. Toxicol. Appl. Pharmacol. 1985; 78: 370–376
   PubMed Web of Science ®Google Scholar
• Ravindranath V., Boyd M. R. Effect of modulators of glutathione synthesis on the hepatotoxicity of 2-methyl-furan. Biochem. Pharmacol. 1991; 41: 1311–1318
   PubMed Web of Science ®Google Scholar
• Nocerini M. R., Carlson J. R., Yost G. S. Glutathione adduct formation with microsomally activated metabolites of the pulmonary alkylating and cytotoxic agent, 3-methylindole. Toxicol. Appl. Pharmacol. 1985; 81: 75–84
   PubMed Web of Science ®Google Scholar
• Yost G. S., Kuntz D. J., McGill L. D. Organ-selective switching of 3-methylindole toxicity by glutathione depletion. Toxicol. Appl. Pharmacol. 1990; 103: 40–51
   PubMed Web of Science ®Google Scholar
• Norcerini M. R., Yost G. S., Carlson J. R., Liberato D. J., Breeze R. G. Structure of the glutathione adduct of activated 3-methylindole indicates that an imine methide is the electrophilic intermediate. Drug Metab. Dispos. 1985; 13: 690–694
   PubMed Web of Science ®Google Scholar
• Pearson P. G., Gescher A., Harpur E. S. Hepatotoxicity of N-methylformamide in mice I. Relationship to glutathione status. Bio-chem. Pharmacol. 1987; 36: 381–384
   PubMed Web of Science ®Google Scholar
• Pearson P. G., Gescher A., Harpur E. S., Threadgill M. D. Hepatotoxicity of N-methylformamide in mice. 2. Covalent binding of metabolites of [l4C]-labeled JV-methylformamide to hepatic proteins. Biochem. Pharmacol. 1987; 36: 385–390
   PubMed Web of Science ®Google Scholar
• Kenekal S., Plopper C., Morin D., Buckpitt A. Metabolism and cytotoxicity of naphthalene oxide in the isolated perfused mouse lung. J. Pharmacol. Exp. Ther. 1991; 256: 391–401
   PubMed Web of Science ®Google Scholar
• D'Arcy Doherty M., Cohen G. Metabolic activation of 1-naphthol by rat liver microsomes to 1,4-naphthaquinone and covalent binding species. Biochem. Pharmacol. 1984; 33: 543–549
   PubMed Web of Science ®Google Scholar
• Buckpitt A. R., Bahnson L. S., Franklin R. B. Evidence that 1-naphthol is not an obligate intermediate in the covalent binding and pulmonary bronchiolar necrosis by naphthalene. Biochem. Biophys. Res. Commun. 1985; 126: 1097–1103
   PubMed Web of Science ®Google Scholar
• Boyd M. R. Effects of oxygen on the disposition of nitrofurantoin in intact rat lung. Drug Metab. Dispos. 1984; 12: 787–789
   PubMed Web of Science ®Google Scholar
• Kedderis G. L., Miwa G. T. The metabolic activation of nitrohet-erocyclic therapeutic agents. Drug Metab. Rev. 1988; 19: 33–62
   PubMed Web of Science ®Google Scholar
• Estep J. E., Lame M. W., Morin D., Jones A. D., Wilson D. W., Segall H. J. [14C]Monocrotaline kinetics and metabolism in the rat. Drug Metab. Dispos. 1991; 19: 135–139
   PubMed Web of Science ®Google Scholar
• Lame M. W., Jones A. D., Morin D., Segall H. J. Metabolism of [l4C]monocrotaline by isolated perfused rat liver. Drug Metab. Dispos. 1991; 19: 516–524
   PubMed Web of Science ®Google Scholar
• Mattocks A. R., Jukes R. Recovery of the pyrrolic nucleus of pyrrolizidine alkaloid metabolites from sulphur conjugates in tissues and body fluids. Chem.-Biol. Interact. 1990; 75: 225–239
   PubMed Web of Science ®Google Scholar
• Dryoff M. C., Neal R. A. Identification of the major protein ad-duct formed in rat liver after thioacetamide administration. Cancer Res. 1981; 41: 3430–3435
   PubMed Web of Science ®Google Scholar
• Dryoff M. C., Neal R. A. Studies of the mechanism of metabolism of thioacetamide 5-oxide by rat liver microsomes. Mot. Pharmacol. 1983; 23: 219–227
   PubMed Web of Science ®Google Scholar
• Porubek D. J., Grillo M. D., Baillie T. A. The covalent binding to protein of valproic acid and its hepatotoxic metabolite, 2-N-propyl-4-pentenoic acid, in rats and in isolated hepatocytes. Drug Metab Dispos. 1989; 17: 123–130
   PubMed Web of Science ®Google Scholar